A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053)

NCT01120600 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Odanacatib
DRUG: Placebo for Odanacatib
DIETARY_SUPPLEMENT: Vitamin D3
DIETARY_SUPPLEMENT: Calcium carbonate

Sponsor

Merck Sharp & Dohme LLC